Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
111,247
datasets available to search
ShareScore release 0.9.0
Dataset results
111,247 results for “cells”
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT01223027. IPD Sharing: Not stated. Countries: 27. Publications: 1.
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remis
ClinicalTrials.gov study NCT00382109. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00559104. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
ClinicalTrials.gov study NCT03783078. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
ClinicalTrials.gov study NCT04195750. IPD Sharing: YES. Countries: 23. Publications: 2.
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
ClinicalTrials.gov study NCT02100891. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.
ClinicalTrials.gov study NCT02968979. IPD Sharing: NO. Countries: 1. Publications: 1.
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01009203. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
ClinicalTrials.gov study NCT02811861. IPD Sharing: Not stated. Countries: 20. Publications: 12.
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration
ClinicalTrials.gov study NCT00447954. IPD Sharing: NO. Countries: 1. Publications: 1.
Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
ClinicalTrials.gov study NCT00957931. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-
ClinicalTrials.gov study NCT04639245. IPD Sharing: NO. Countries: 1. Publications: 1.
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
ClinicalTrials.gov study NCT01231412. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
ClinicalTrials.gov study NCT03322540. IPD Sharing: NO. Countries: 18. Publications: 1.
Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04735068. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
ClinicalTrials.gov study NCT02267603. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00323869. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)
ClinicalTrials.gov study NCT03565900. IPD Sharing: YES. Countries: 10. Publications: 1.
Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome
ClinicalTrials.gov study NCT01287078. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
ClinicalTrials.gov study NCT03037385. IPD Sharing: NO. Countries: 13. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.